Kenichi Tanaka to Anticoagulants
This is a "connection" page, showing publications Kenichi Tanaka has written about Anticoagulants.
Connection Strength
4.879
-
Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery. J Cardiothorac Vasc Anesth. 2019 Aug; 33(8):2153-2160.
Score: 0.539
-
Perioperative Coagulation Management of a Hemophilia A Patient During Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2017 Dec; 21(4):312-320.
Score: 0.477
-
Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery. J Anesth. 2016 06; 30(3):369-76.
Score: 0.438
-
Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model. J Cardiothorac Vasc Anesth. 2013 Dec; 27(6):e69-71.
Score: 0.374
-
Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):1026-7.
Score: 0.289
-
In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. J Cardiothorac Vasc Anesth. 2010 Jun; 24(3):408-12.
Score: 0.284
-
In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry. Thromb Haemost. 2009 May; 101(5):827-33.
Score: 0.275
-
Anticoagulation and reversal paradigms: is too much of a good thing bad? Anesth Analg. 2009 Mar; 108(3):692-4.
Score: 0.272
-
Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):106-8.
Score: 0.251
-
Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesth Analg. 2007 Oct; 105(4):933-9, table of contents.
Score: 0.247
-
The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004 Nov; 99(5):1283-1289.
Score: 0.202
-
Heparin-Induced Thrombocytopenia in Patients With Mechanical Circulatory Support. J Cardiothorac Vasc Anesth. 2022 07; 36(7):1880-1882.
Score: 0.169
-
Hereditary Antithrombin Deficiency: A Balancing Act of Perioperative Hemostasis and Thromboprophylaxis-A Case Report. A A Pract. 2021 Dec 17; 15(12):e01550.
Score: 0.165
-
Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding. Transfus Med Rev. 2021 10; 35(4):96-103.
Score: 0.162
-
Toward Optimal Anticoagulation Monitoring During Cardiopulmonary Bypass: It Is Still A Tough "ACT". J Cardiothorac Vasc Anesth. 2020 11; 34(11):2928-2930.
Score: 0.150
-
CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin. J Cardiothorac Vasc Anesth. 2016 Dec; 30(6):1709-1715.
Score: 0.111
-
The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Anesth Analg. 2012 Aug; 115(2):244-52.
Score: 0.085
-
Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth. 2010 Dec; 24(6):959-63.
Score: 0.074
-
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res. 2008; 122(1):117-23.
Score: 0.062
-
Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Anesth Analg. 2007 Sep; 105(3):570-82.
Score: 0.061
-
Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa. Anesth Analg. 2007 Apr; 104(4):763-5.
Score: 0.060
-
A novel method to assess platelet inhibition by eptifibatide with thrombelastograph. Anesth Analg. 2004 Dec; 99(6):1794-1799.
Score: 0.051
-
Antiplatelet agents and bleeding after cardiac surgery. Anesth Analg. 2004 Sep; 99(3):947-948.
Score: 0.050
-
A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery. J Cardiothorac Vasc Anesth. 2018 08; 32(4):1609-1614.
Score: 0.031